StockNews.com Downgrades Corvus Pharmaceuticals (NASDAQ:CRVS) to Sell
Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. CRVS has been the subject of several other research reports. HC Wainwright reissued a “buy” rating and issued a $11.00 price target on shares of […]
Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. CRVS has been the subject of several other research reports. HC Wainwright reissued a “buy” rating and issued a $11.00 price target on shares of […]
